About Nuevo Therapeutics Private Limited
Data last updated:
Nuevo Therapeutics Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 January 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2013PTC085338. Its GSTIN is 36AAECN2306D1ZZ (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Priyatham Reddy Chennareddy and Geetha Reddy Channa.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at M. No. 8 – 2 – 502/1/A Jivi Towers Road No. 7 Banjara Hills, Hyderabad, Telangana, India – 500034.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.11 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹1.49 Lakh (net margin 1.3%) and EBITDA of ₹3.26 Lakh (EBITDA margin 2.9%). Revenue has declined at a compounded annual rate (CAGR) of 14% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nuevo.co.in.
Company details
CIN history
Nuevo Therapeutics has one previous CIN (Corporate Identification Number): U24232AP2013PTC085338. The current CIN is U24232TG2013PTC085338, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2013PTC085338 | Current |
| U24232AP2013PTC085338 | Previous |
Contact details
Nuevo Therapeutics Private Limited's registered office is in Hyderabad, Telangana. Its website is nuevo.co.in. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressM. No. 8 – 2 – 502/1/A Jivi Towers Road No. 7 Banjara Hills, Hyderabad, Telangana, India – 500034
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Nuevo Therapeutics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Nuevo Therapeutics is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Nuevo Therapeutics Private Limited, buy the company report.
Financials of Nuevo Therapeutics Private Limited
FY 2025 filings availableNuevo Therapeutics Private Limited reported revenue of ₹1.11 Cr (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 6% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 14%. EBITDA rose 55% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.26 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.49 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.9% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nuevo Therapeutics Private Limited, buy the company report.
Board of directors of Nuevo Therapeutics Private Limited
Nuevo Therapeutics has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Priyatham Reddy Chennareddy | Director | 10 Jan 2013 | 13 Years 9 Months | Current |
| Geetha Reddy Channa | Director | 10 Jan 2013 | 13 Years 9 Months | Current |
| Mitra Puchhalapalli Also directs: Genova Biotechniques Private Limited | Director | 10 Jan 2013 | 13 Years 9 Months | Current |
Peer comparison
Nuevo Therapeutics Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gromaxformulations Private Limited | ₹1.12 Cr (FY 2025) | -31.0% | Sriperumbudur, Tamil Nadu, India | |||
| Hermes Animal Health Care Private Limited | ₹1.12 Cr (FY 2024) | -86.0% | Coimbatore, Tamil Nadu, India | |||
| Tricent Pharmaceuticals Private Limited | ₹1.11 Cr (FY 2024) | 7056835.0% | Lucknow, Uttar Pradesh, India | |||
| Nuevo Therapeutics Private Limitedthis company | ₹1.11 Cr (FY 2025) | ₹1.49 Lakh | 1.3% | 6.0% | Hyderabad, Telangana, India | |
| Shivaste Traders Private Limited | ₹1.11 Cr (FY 2024) | 5.0% | Greater Noida West, Uttar Pradesh, India | |||
| Cellestus Pharmaceuticals Private Limited | ₹1.11 Cr (FY 2024) | 122.0% | Baddi, Himachal Pradesh, India | |||
| Quantrix Healthcare Private Limited | ₹1.11 Cr (FY 2020) | -34.0% | Indore, Madhya Pradesh, India |
To see the full peer comparison of Nuevo Therapeutics Private Limited, buy the company report.
Auditor
Nuevo Therapeutics Private Limited is audited by B R R & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B R R & ASSOCIATES | FY 2021 | 013012S |
Shareholding
The shareholding of Nuevo Therapeutics Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Nuevo Therapeutics Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Nuevo Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nuevo Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nuevo Therapeutics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAECN2306D1ZZ | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Nuevo Therapeutics Private Limited, buy the company report.
Recent activity
Nuevo Therapeutics Private Limited has 3 board changes on record since 2013: 3 appointments. The latest: Geetha Reddy Channa was appointed as Director on 10 Jan 2013.
Frequently asked questions
Nuevo Therapeutics is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 January 2013 (13+ years old) and is registered under CIN U24232TG2013PTC085338.
Nuevo Therapeutics has 3 current directors:
- Priyatham Reddy Chennareddy - Director
- Geetha Reddy Channa - Director
- Mitra Puchhalapalli - Director
The latest financial statements of Nuevo Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Nuevo Therapeutics is 36AAECN2306D1ZZ, registered in Telangana.
The CIN (Corporate Identification Number) of Nuevo Therapeutics is U24232TG2013PTC085338. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nuevo Therapeutics was incorporated on 10 January 2013, making it 13+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Nuevo Therapeutics by revenue are Gromaxformulations Private Limited, Hermes Animal Health Care Private Limited, Tricent Pharmaceuticals Private Limited, Shivaste Traders Private Limited, Cellestus Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Geetha Reddy Channa was appointed as Director on 10 Jan 2013. Mitra Puchhalapalli was appointed as Director on 10 Jan 2013. Priyatham Reddy Chennareddy was appointed as Director on 10 Jan 2013.
Nuevo Therapeutics can be reached through the website nuevo.co.in. Its registered office is in Hyderabad, Telangana, India.
The registered office of Nuevo Therapeutics is at M. No. 8 – 2 – 5021A Jivi Towers Road No. 7 Banjara Hills, Hyderabad, Telangana, India – 500034.
Nuevo Therapeutics operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
